Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 64

1.

Hereditary hemorrhagic telangiectasia patient presenting with brain abscess due to silent pulmonary arteriovenous malformation.

Themistocleous M, Giakoumettis D, Mitsios A, Anagnostopoulos C, Kalyvas A, Koutsarnakis C.

Pan Afr Med J. 2016 Nov 11;25:145. doi: 10.11604/pamj.2016.25.145.11010. eCollection 2016.

2.

Mutation affecting the proximal promoter of Endoglin as the origin of hereditary hemorrhagic telangiectasia type 1.

Albiñana V, Zafra MP, Colau J, Zarrabeitia R, Recio-Poveda L, Olavarrieta L, Pérez-Pérez J, Botella LM.

BMC Med Genet. 2017 Feb 23;18(1):20. doi: 10.1186/s12881-017-0380-0.

3.

Non-invasive CT screening for pulmonary arteriovenous malformations in children with confirmed hereditary hemorrhagic telangiectasia: Results from two pediatric centers.

Soysal N, Eyries M, Verlhac S, Escabasse V, Remus N, Tamalet A, Rioux JY, Franchi-Abella S, Vasile M, Robert S, Delestrain C, Hau I, Ducou-Le Pointe H, Soubrier F, Carette MF, Epaud R.

Pediatr Pulmonol. 2017 May;52(5):642-649. doi: 10.1002/ppul.23649. Epub 2017 Feb 6.

PMID:
28165669
4.

Sinonasal quality of life outcomes following laser treatment of epistaxis related to hereditary hemorrhagic telangiectasia.

Kuan EC, Peng KA, Thompson CF, Suh JD, Wang MB.

Lasers Med Sci. 2017 Apr;32(3):527-531. doi: 10.1007/s10103-017-2144-7. Epub 2017 Jan 24.

PMID:
28116537
5.

Hereditary hemorrhagic telangiectasia, liver disease and elevated serum testosterone (Osler-Weber-Rendu syndrome): a case report.

Dissanayake R, Wickramarathne KP, Seneviratne SN, Perera SN, Fernando MU, Wickramasinghe VP.

BMC Res Notes. 2017 Jan 23;10(1):58. doi: 10.1186/s13104-017-2397-z.

6.

Quality of life in patients with hereditary haemorrhagic telangiectasia (HHT).

Zarrabeitia R, Fariñas-Álvarez C, Santibáñez M, Señaris B, Fontalba A, Botella LM, Parra JA.

Health Qual Life Outcomes. 2017 Jan 23;15(1):19. doi: 10.1186/s12955-017-0586-z.

7.

Influence of temporary nasal occlusion (tNO) on epistaxis frequency in patients with hereditary hemorrhagic telangiectasia (HHT).

Wirsching KEC, Haubner F, Kühnel TS.

Eur Arch Otorhinolaryngol. 2017 Apr;274(4):1891-1896. doi: 10.1007/s00405-016-4431-5. Epub 2017 Jan 9.

PMID:
28070641
8.

Nasal powders of thalidomide for local treatment of nose bleeding in persons affected by hereditary hemorrhagic telangiectasia.

Colombo G, Bortolotti F, Chiapponi V, Buttini F, Sonvico F, Invernizzi R, Quaglia F, Danesino C, Pagella F, Russo P, Bettini R, Colombo P, Rossi A.

Int J Pharm. 2016 Nov 30;514(1):229-237. doi: 10.1016/j.ijpharm.2016.07.002.

9.
10.

Effect of Center Volume on Outcomes in Hospitalized Patients With Hereditary Hemorrhagic Telangiectasia.

Iyer VN, Brinjikji W, Pannu BS, Apala DR, Lanzino G, Cloft HJ, Misra S, Krowka MJ, Wood CP, Swanson KL.

Mayo Clin Proc. 2016 Dec;91(12):1753-1760. doi: 10.1016/j.mayocp.2016.07.005. Epub 2016 Nov 1.

PMID:
27814895
11.

Improvement in hereditary hemorrhagic telangiectasia after treatment with the multi-kinase inhibitor Sunitinib.

Droege F, Thangavelu K, Lang S, Geisthoff U.

Ann Hematol. 2016 Dec;95(12):2077-2078. Epub 2016 Aug 15. No abstract available.

PMID:
27525726
13.

Defective fluid shear stress mechanotransduction mediates hereditary hemorrhagic telangiectasia.

Baeyens N, Larrivée B, Ola R, Hayward-Piatkowskyi B, Dubrac A, Huang B, Ross TD, Coon BG, Min E, Tsarfati M, Tong H, Eichmann A, Schwartz MA.

J Cell Biol. 2016 Sep 26;214(7):807-16. doi: 10.1083/jcb.201603106. Epub 2016 Sep 19.

14.

Cancer incidence in patients with hereditary hemorrhagic telangiectasia.

Duarte CW, Black AW, Lucas FL, Vary CP.

J Cancer Res Clin Oncol. 2017 Feb;143(2):209-214. doi: 10.1007/s00432-016-2272-7. Epub 2016 Sep 16.

PMID:
27638773
15.

Effect of Topical Intranasal Therapy on Epistaxis Frequency in Patients With Hereditary Hemorrhagic Telangiectasia: A Randomized Clinical Trial.

Whitehead KJ, Sautter NB, McWilliams JP, Chakinala MM, Merlo CA, Johnson MH, James M, Everett EM, Clancy MS, Faughnan ME, Oh SP, Olitsky SE, Pyeritz RE, Gossage JR.

JAMA. 2016 Sep 6;316(9):943-51. doi: 10.1001/jama.2016.11724.

PMID:
27599329
16.

Hereditary Hemorrhagic Telangiectasia.

Parambil JG.

Clin Chest Med. 2016 Sep;37(3):513-21. doi: 10.1016/j.ccm.2016.04.013. Epub 2016 Jun 10. Review.

PMID:
27514597
17.

Reply to Letter Regarding "Amplatzer Vascular Plugs Versus Coils for Embolization of Pulmonary Arteriovenous Malformations in Patients with Hereditary Hemorrhagic Telangiectasia".

Tau N, Atar E, Mei-Zahav M, Bachar GN, Dagan T, Birk E, Bruckheimer E.

Cardiovasc Intervent Radiol. 2016 Oct;39(10):1520. doi: 10.1007/s00270-016-1448-5. Epub 2016 Aug 9. No abstract available.

PMID:
27506772
18.

Regarding "Amplatzer Vascular Plugs Versus Coils for Embolization of Pulmonary Arteriovenous Malformations in Patients with Hereditary Hemorrhagic Telangiectasia".

Jia Z, Li S, Jiang G.

Cardiovasc Intervent Radiol. 2016 Oct;39(10):1519. doi: 10.1007/s00270-016-1441-z. Epub 2016 Aug 8. No abstract available.

PMID:
27501797
19.

Screening for arteriovenous malformations in hereditary haemorrhagic telangiectasia.

Jervis S, Skinner D.

J Laryngol Otol. 2016 Aug;130(8):734-42. doi: 10.1017/S0022215116008422. Epub 2016 Jul 5.

PMID:
27377139
20.

Treatment of Hereditary Hemorrhagic Telangiectasia-Related Epistaxis.

Sautter NB, Smith TL.

Otolaryngol Clin North Am. 2016 Jun;49(3):639-54. doi: 10.1016/j.otc.2016.02.010. Review.

PMID:
27267016

Supplemental Content

Loading ...
Support Center